Skip to main content

Month: April 2022

CGG: CGG Announces New Segment Reporting Names and Q1 2022 Financial Results Conference Call Details

CGG Announces New Segment Reporting Names and Q1 2022 Financial Results Conference Call Details PARIS, France – April 19, 2022 New Segment Reporting Names   With CGG continuing to accelerate its development of a portfolio of unique technologies and proven expertise focused on rapidly growing new beyond the core markets, and to reflect the evolution of the Group into a Technology company, new segment reporting names will used from Q1 2022 financial reporting, which will be communicated on May 4, 2022. CGG will continue to present its financial information under two reporting segments, renaming them as follows:Geophysics, Geology and Reservoir (GGR) reporting segment will be renamed into Data, Digital & Energy Transition (DDE):Geoscience business will keep its name as Geoscience (GEO), and Multi-Client business will be renamed...

Continue reading

Pixium Vision announces its cash position at 31 March 2022 and provides an update on its activities and financial outlook until the end of 2022

Pixium Vision announces its cash position at 31 March 2022 and provides an update on its activities and financial outlook until the end of 2022 Paris, France, April 19, 2022 – 07:00 CET– Pixium Vision SA (Euronext Growth Paris – FR0011950641), a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independently, announces a cash position of €10.4 million at 31 March 2022 and reports on its key developments. In total, at 31 March 2022, Pixium Vision’s cash position amounted to €10.4 million, compared to €14.5 million on 1 January 2022. Given its current cash position, the Company’s financial runway extends until the end of this year. Pixium Vision is continuing to explore various avenues that will enable it to secure the cash flow necessary to pursue its development....

Continue reading

LHV Group unaudited results for Q1 2022

In Q1 2022, AS LHV Group earned a total of EUR 12.4 million in consolidated net profit. Within the quarter, AS LHV Bank earned EUR 14.9 million in net profit, including EUR 2.7 million from servicing clients related to the United Kingdom branch. During Q1, AS LHV Varahaldus generated EUR 0.6 million in net loss, and AS LHV Kindlustus generated EUR 0.5 million in net loss. LHV UK Limited had a loss of EUR 1.6 million. The Group’s return on equity in Q1 was 14.7%. The net profit for Q1 was EUR 1 million higher than Q1 a year ago (+8%), and EUR 7 million lower than in 2021 Q4 (-36%), when the profit also included the success fee related to managing pension funds. The Group’s consolidated revenue in Q1 was EUR 34.8 million, i.e. EUR 6 million more than a year earlier (+21%) and EUR 7.9 million less than in Q4 (-18%). At the same time, the...

Continue reading

Q1 2022 Trading Update and Invitation to Earnings Call

Oslo, 19 April 2022 – DNO ASA, the Norwegian oil and gas operator, will publish its Q1 2022 operating and interim financial results on Thursday, 12 May 2022 at 07:00 (CET). A videoconference call with executive management will follow at 11:00 (CET). The Company issues below an update on production and sales volumes for the quarter as well as other key financial information that will be further discussed in the earnings call.Volumes (boepd)Gross operated production Q1 2022 Q4 2021 Q1 2021  Kurdistan 106,465 107,472 111,985  North Sea – – –       Net entitlement production Q1 2022 Q4 2021 Q1 2021  Kurdistan 26,670 29,367 28,593  North Sea 12,700 13,571 15,173       Sales Q1 2022 Q4 2021 Q1 2021  Kurdistan 26,670 29,367 28,593  North Sea 10,689 23,289 10,953Selected cash flow items During the quarter,...

Continue reading

Biotalys Appoints Michiel van Lookeren Campagne to Board of Directors

Prominent industry leader strengthens company’s leadership in plant science and technology Ghent, BELGIUM and Durham, NC, USA, April 19, 2022 (GLOBE NEWSWIRE) — Press releaseBiotalys (Euronext: BTLS), an Agricultural Technology (AgTech) company protecting crops and food with protein-based biocontrol solutions, today announced the appointment of Dr. Michiel van Lookeren Campagne to its Board of Directors, following its annual shareholders meeting last week. “We are delighted to welcome Michiel to the board of Biotalys,” commented Simon Moroney, Chairman of Biotalys. “With decades of experience driving scientific advances for the agricultural industry in leadership positions around the globe, Michiel will bring valuable perspectives to the Board in support of the company’s efforts to make protein-based biocontrols a standard part...

Continue reading

Rubicon Organics Reports Fourth Quarter 2021 Financial Results and Operational Update

$6.8 million in net revenue, 43% increase over Q4 2020 Achieved first ever quarter of positive cashflows from operations 7.6% national market share of premium flower and pre-rolls1 #1 Premium flower and pre-roll brand in Canada with Simply BareTM Organic2VANCOUVER, British Columbia, April 18, 2022 (GLOBE NEWSWIRE) — Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified, premium cannabis, today reported its financial results for the fourth quarter ended December 31, 2021 (“Q4 2021”). All amounts are expressed in Canadian dollars. “Building premium brands that consumers love and are loyal to begins with a culture that prioritizes quality. We have invested in our facility and our cultivation systems which have resulted in...

Continue reading

Affinor Growers Ships Its Third Order of Premium Vine-Ripened Strawberries and Expands Distribution

VANCOUVER, British Columbia, April 18, 2022 (GLOBE NEWSWIRE) — Affinor Growers Inc. (“Affinor” or the “Company”) (CSE: AFI; OTCQB: RSSFF) is pleased to announce that it has shipped its second order of vertically grown, vine ripened, Delizzimo strawberries to Four Seasons Farm at the global tourist attraction, Granville Island Public Market. The company has also shipped its first order of strawberries to the IGA on Robson Street in Vancouver. The demand for this premium, sustainable, greenhouse product is increasing as the word spreads throughout the industry. This shows the need and potential for high quality fresh produce sold as an Abbotsford local product through distributor, Berrymobile. The strawberry harvest, packaging and delivery to local markets represents a successful commercial pilot of Affinor’s patented rotating towers...

Continue reading

Hunter Technology Announces Application for Management Cease Trade Order

VANCOUVER, British Columbia, April 18, 2022 (GLOBE NEWSWIRE) — Hunter Technology Corp. (TSX- V: HOC; OTCQB: HOILF; WKN: A2QEYH, FSE: RWPM, ISIN: CA4457371090) (“Hunter” or the “Corporation”) announces that it has made an application to the British Columbia Securities Commission to approve a temporary management cease trade order (“MCTO“) under National Policy 12-203 – Cease Trade Orders for Continuous Disclosure Defaults (“NP 12-203“), which, if granted, will prohibit trading in securities of the Corporation by the Chief Executive Officer and Chief Financial Officer of the Corporation until such time as the Required Filings (defined below) and all continuous disclosure requirements have been filed by the Corporation, and the MCTO has been lifted. During the period in which the MCTO is effective, the...

Continue reading

Wesana Is Exploring Broadening SANA-013 Lead Indication to Treat Major Depressive Disorder

Concurrently, the Company is launching a non-brokered private placement NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CHICAGO and TORONTO, April 18, 2022 (GLOBE NEWSWIRE) — Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care paradigms today, is pleased to announce that following the completion of a successful Pre-IND meeting with the United States Food and Drug Administration (the “FDA”), the Company is exploring the opportunity to expand its lead indication for SANA-013 to Major Depressive Disorder (“MDD”) following the completion by the Company of a non-brokered private placement (the “Placement”). Consistent with the positive feedback received...

Continue reading

Gold Standard Ventures Announces 2022 Exploration Program

VANCOUVER, British Columbia, April 18, 2022 (GLOBE NEWSWIRE) — Gold Standard Ventures Corp. (NYSE AMERICAN: GSV) (TSX: GSV) (“Gold Standard” or the “Company”) today announced plans for its 2022 first stage exploration program on its +21,000 hectare land package in Nevada’s Carlin Trend. The first stage program includes approximately 5,700 meters of reverse-circulation (“RC”) and core drilling over 20 holes. Drilling is scheduled to start in May 2022. Based on the results of the first stage exploration program, the Company intends to develop a second stage exploration program to be completed in the Fall and Winter of 2022. https://goldstandardv.com/site/assets/files/6188/2022_exploration_program_graphics.pdf Jason Attew, President and CEO, commented, “We are excited to initiate our 2022 drilling program. The focus of this year’s...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.